Repositioning Implementation Science in the HIV Response: Looking Ahead From AIDS 2018.

Hargreaves, James; Dalal, Shona; Rice, Brian; Anderegg, Nanina; Bhattacharjee, Parinita; Gafos, Mitzy; Hensen, Bernadette; Mangenah, Collin; Quaife, Matthew; Padian, Nancy (2019). Repositioning Implementation Science in the HIV Response: Looking Ahead From AIDS 2018. Journal of acquired immune deficiency syndromes JAIDS, 82 Suppl 3, S299-S304. Lippincott Williams & Wilkins 10.1097/QAI.0000000000002209

[img] Text
Hargreaves JAcquirImmuneDeficSyndr 2019.pdf - Published Version
Restricted to registered users only until 2 December 2020.
Available under License Publisher holds Copyright.

Download (93kB) | Request a copy

BACKGROUND Implementation science (IS) occupies a critical place in HIV/AIDS research, reflected by a scientific track ("Track E") at the biannual International AIDS Conference. IS seeks to identify health delivery strategies that cost-effectively translate the efficacy of evidence-based interventions for HIV prevention, testing, and treatment into impact on HIV incidence, quality of life, and mortality. METHOD We reviewed the content of Track E, and other presentations relevant to IS, at the 22nd International AIDS Conference held in Amsterdam in 2018. We identified key findings and themes and made recommendations for areas where the field can be strengthened by the 2020 meeting. RESULTS Trials of "treat all" strategies in Africa showed mixed evidence of effect. Innovations in HIV testing included expanding self-testing and index testing, which are reaching groups, such as men, where previously testing rates have been low. Adherence clubs and other innovations are being trialed to improve retention in care, with mixed findings. The implementation of pre-exposure prophylaxis for HIV prevention continues but with many challenges remaining in identifying implementation strategies that strengthen demand and support continuation. DISCUSSION IS for HIV/AIDS treatment and prevention continues to expand. IS for primary HIV prevention must be prioritized with a dearth of rigorous, intersectoral studies in this area. The weakness of routine data must be addressed. Costing and financing studies should form a stronger component of the conference agenda. Implementation scientists must continue to grapple with the methodological challenges posed by the real-world context for their research.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Anderegg, Nanina Tamar

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

0894-9255

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Andrea Flükiger-Flückiger

Date Deposited:

03 Dec 2019 14:57

Last Modified:

17 Dec 2019 15:25

Publisher DOI:

10.1097/QAI.0000000000002209

PubMed ID:

31764267

BORIS DOI:

10.7892/boris.136005

URI:

https://boris.unibe.ch/id/eprint/136005

Actions (login required)

Edit item Edit item
Provide Feedback